Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy |
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) | Phase3 | Germany United States |
NCT07498426 |
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) |
Primary Immune Thrombocytopenia (ITP), Primary Evans Syndrome (ES) | Phase2 | United States | NCT07421167 |
Pediatric Long-Term Follow-up and Rollover Study |
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood, Anaplastic Oligodendroglioma, Glioblastoma, Pilocytic Astrocytoma, Giant Cell Astrocytoma, Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, Angiocentric Glioma, Chordoid Glioma of Third Ventricle, Gangliocytoma, Ganglioglioma, Anaplastic Ganglioglioma, Dysplastic Gangliocytoma of Cerebrellum, Desmoplastic Infantile Astrocytoma and Ganglioglioma, Papillary Glioneuronal Tumor, Rosette-forming Glioneuronal Tumor, Central Neurocytoma, Extraventricular Neurocytoma, Cerebellar Liponeurocytoma, Neurofibromatosis Type 1 | Phase4 | United States | NCT03975829 |
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies |
Heterozygous or Homozygous Familial Hypercholesterolemia | Phase3 | Taiwan | NCT05682378 |
Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis |
Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) | Phase1 | Japan | NCT07340138 |
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP |
Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive | Phase2 | Australia Canada South Korea |
NCT07354074 |
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population |
Hidradenitis Suppurativa | Italy | NCT07543419 | |
REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria |
Paroxysmal Nocturnal Hemoglobinuria (PNH) | Italy | NCT07229235 | |
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) |
Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) | Phase3 | Australia China South Korea Switzerland United States View all |
NCT07357727 |
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction |
Heart Failure With Reduced Ejection Fraction | Phase1 | United States | NCT07465653 |